Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.3800
-0.0240 (-5.94%)
At close: May 8, 2026, 4:00 PM EDT
0.3682
-0.0118 (-3.11%)
After-hours: May 8, 2026, 7:46 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $263.31 thousand as of May 8, 2026. Its market cap has decreased by -73.76% in one year.
Market Cap
263.31K
Enterprise Value
-4.91M
1-Year Change
-73.76%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $633.29M to $263.31K, a decrease of -99.96%. That is a compound annual growth rate of -84.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 263.31K | -89.15% |
| Dec 31, 2025 | 2.43M | -53.58% |
| Dec 31, 2024 | 5.23M | 43.62% |
| Dec 29, 2023 | 3.64M | -78.62% |
| Dec 30, 2022 | 17.02M | -97.31% |
| Feb 18, 2022 | 633.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.59M |
| Artelo Biosciences | 2.38M |
| Bone Biologics | 2.36M |
| HCW Biologics | 2.21M |
| Adial Pharmaceuticals | 2.04M |
| Scinai Immunotherapeutics | 1.97M |
| Propanc Biopharma | 1.85M |
| Silexion Therapeutics | 1.75M |